One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Editorial Board
doi : 10.1016/S0015-0282(25)01803-5
Volume 124, Issue 3, September 2025, Pages A1-A3
Celebrating 75 years of Fertility and Sterility with the past editors-in-chief: Drs. Craig Niederberger and Antonio Pellicer, 2011–2021
Male fertility restoration with stem cell–based therapies: from testicular stem cells to pluripotent stem cell–based in vitro gametogenesis
The use of testicular organoids in advancing future treatments for male factor infertility
Intratesticular autologous platelet-rich plasma injection in couples with nonobstructive azoospermia: a narrative review
Addressing the endometriosis gap and promoting equal access to care for Black women with endometriosis
Comparing blastulation of surgically retrieved sperm with ejaculated sperm in donor oocyte cycles
Position statement on nurses and advanced practice providers performing focused ultrasound examinations in a gynecology or infertility setting
Refining assisted reproductive technology strategy in nonobstructive azoospermia: synchrony, sperm quality, and oocyte availability
A shot in the dark: intraovarian platelet-rich plasma continues to offer guarded optimism
In vitro fertilization and the chorionic bump: when a small finding sparks big fears
Gonadotropin-releasing hormone antagonist in uterine adenomyosis: some light at the end of the tunnel
A commentary on “Online fertility workup with video consultation for infertility patients; a randomized controlled trial�
Can glucagon-like peptide 1 agonists redefine polycystic ovary syndrome weight loss management?
Fertilization and embryo development in fresh vs. vitrified oocytes with sperm from men with nonobstructive azoospermia
Patients with a body mass index of ≥45 kg/m2 can safely undergo oocyte retrievals and anticipate similar assisted reproductive technology outcomes
Increasing endometrial thickness up to 12 mm is associated with increased odds of live birth among fresh and frozen-thawed autologous transfers with or without preimplantation genetic testing
The number of autologous, vitrified mature oocytes needed to obtain three euploid blastocysts increases with age
Impact of bilateral intraovarian platelet-rich plasma in women with poor ovarian response or primary ovarian insufficiency: a retrospective study
Effect of vanishing twin on singleton neonatal outcomes in frozen embryo transfer cycles
The chorionic bump is a predictor of miscarriage: a retrospective analysis of 13,656 in vitro fertilization pregnancies
Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2
Online fertility workup with video consultation for infertility patients; a randomized controlled trial
Prospective validation of anti-Müllerian hormone cutoff to determine polycystic ovarian morphology: HARMONIA study
Racial and ethnic differences in gestational carriers: assessment of obstetric characteristics and outcomes
Pregnancy outcomes are compromised in obese women with polycystic ovary syndrome after transfer of a single frozen-thawed euploid embryo
Effect of glucagon-like peptide 1 receptor agonist medications on weight loss in patients with and without polycystic ovary syndrome
Hysteroscopic visualization and resection of embryo in biochemical pregnancy loss
Eight steps to success: minimally invasive surgical management of cesarean scar pregnancy
Natural vs. modified natural frozen-thawed embryo transfer cycles
Reply of the authors: Natural vs modified natural frozen thawed embryo transfer cycles
The missing pieces in clomiphene citrate safety data: long-term outcomes and genetic considerations
Refining glucagon-like peptide-1 receptor agonist therapy in polycystic ovary syndrome: addressing phenotypic, racial, and pharmacologic heterogeneity
Reply of the authors: Refining glucagon-like peptide-1 receptor agonist therapy in polycystic ovary syndrome: addressing phenotypic, racial, and pharmacologic heterogeneity
Expression of concern ‘Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial’ [Fertil Steril 2015; 103:101-5]
